News >

Long-Term Evidence Supports Use of SBRT in Prostate Cancer

Kristi Rosa
Published: Wednesday, Feb 13, 2019

Amar U. Kishan, MD

Amar U. Kishan, MD

Stereotactic body radiation therapy (SBRT) has been found to be a safe and effective option for patients with low- and intermediate-risk prostate cancer, according to long-term outcome data recently published in JAMA Network Open.1

 

References

  1. Kishan AU, Dang A, Katz AJ, et al. Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer. JAMA Netw Open. 2019;2(2):e188006. doi: 10.1001/jamanetworkopen.2018.8006.
  2. Shorter Course Of Radiation Therapy Effective In Treating Men With Prostate Cancer UCLA. Published February 8, 2019. https://bit.ly/2DyzXd6. Accessed February 12, 2019.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 3rd Annual International Congress on Oncology & Pathology™Aug 30, 20201.5
Community Practice Connections™: ASCO Direct™ Highlights – 2019 Official Annual Meeting ReviewAug 30, 20201.5
Publication Bottom Border
Border Publication
x